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Abstract: To tackle one of the biggest global health problems, the resistance of microorganisms to 
antibiotics, a collective effort in the search for more effective agents against bacteria was required. 
Peptides with antimicrobial activity have been raising much attention as a promising alternative for 
antibiotics. Peptaibols, for instance, are a family of antimicrobial peptides (AMPs) with great 
biomedical potential, in which the Peptaibolin can be highlighted. This peptide has gained relevance 
due to its small amino acids content, only four, and its acetyl group and a phenylalaninol residue 
(Phol) at the N-terminal and C-terminal, respectively. Here, we report the synthesis of Peptaibolin 
through Solid Phase Peptide Synthesis assisted by Microwave heating (MW-SPPS) in a pre-loaded 
Phe-Wang resin. Starting from a loading of 0.51 mmol/g, two syntheses were made, using two 
different combinations of coupling reagents. The best option was DIC/Oxima, achieving a yield of 
50.0%. Proton Nuclear Magnetic Resonance (1H-NMR) studies confirmed the peptide structure, 
while High Performance Liquid Chromatography (HPLC) verified the peptide purity. The peptide 
solubility was examined against several combinations of solvents. Peptaibolin was not soluble in 
water, only in organic solvents or in the combination of both. Antimicrobial testing was conducted 
using Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa. 
Minimum inhibitory concentration studies demonstrated the resistance of bacteria to the peptide 
action and the peptide instability in bacterial growth conditions. 
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1. Introduction 
The discovery of antibiotics is considered one of the greatest and best achievements 
in the scientific world and for the pharmaceutical industry. For years, they have been the 
most effective treatment against one of the biggest causes of death worldwide, systemic 
infections, the result of the action of a wide spectrum of pathogenic microorganisms. 
However, nowadays, these are no longer a 100% effective solution in the fight against 
bacterial infections due to the development of resistance from both Gram-positive and 
Gram-negative bacteria, including: Staphylococcus aureus, Enterococcus spp., Pseudomonas 
aeruginosa, and Escherichia coli [1–3]. To battle this obstacle, some functional strategies 
were developed to replace the action of conventional antibiotics with biomolecules with 
similar pharmacological characteristics, like peptides with antimicrobial activity (AMPs). 
The effectiveness of AMPs is reflected in their mechanisms of action, affecting cell 
membranes in different ways, changing their permeability, or causing the membrane to 
rupture entirely. Such mechanisms are not common to all types of peptides and depend 
on their molecular properties and the type of bacterial and/or cellular target, including 
DNA, RNA, regulatory enzymes, and other proteins. Generally, the damage caused to 
bacteria by AMPs is difficult to correct and the possibility that they develop resistance to 
these peptides is believed to be remote [4–6]. 
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Peptaibols are a family of AMPs isolated from the fungal strain Trichoderma and have 
antibacterial and antifungal properties. The main characteristic of this type of AMP is the 
presence of non-proteinogenic amino acids which are not encoded by DNA, such as α-
aminobutyric acid (Aib) and isovaline (Iva). This class of amino acids is often used in 
peptides of pharmacological interest since they are not recognized by hydrolytic enzymes, 
improving their biodegradability and increasing their bioavailability [7,8]. One of the 
most unique AMPs in this family is Peptaibolin because it is the smallest in the peptaibol 
family, but at the same time, it has a three-dimensional structure comparable to the larger 
peptaibols. It contains an N-terminal acetyl group and a C-terminal phenylalaninol (Phol) 
residue, together with only four amino acids (Ac-Leu-Aib-Leu-Aib-Phol) (Figure 1). 
Crisma et al. studied Peptaibolin and concluded that this small peptide had antimicrobial 
activity, albeit moderate, in Gram-positive bacteria. Its mode of action is based on the 
permeabilization of the cell membrane causing its rupture. Through conformational 
studies by X-ray crystallography, it was detected that Peptaibolin has an extremely folded 
secondary α-helix structure and its antimicrobial activity is directly related to this fact, 
since this conformation allows for aggregation, an unusual feature in peptides with few 
amino acid residues [9]. 
 
Figure 1. Structure of the antimicrobial peptide (AMP) Peptaibolin containing an N-terminal acetyl 
group and a C-terminal phenylalaninol (Phol) residue, encompassing only four amino acid 
residues (Ac-Leu-Aib-Leu-Aib-Phol). 
The synthesis of Peptaibolin and all peptaibols in general is significantly impaired by 
stereochemical impediment in residues such as Aib, where the reactivity during the 
coupling reaction is decreased compared to other amino acid residues. To overcome this 
difficulty, it is necessary to use a selection of suitable coupling reagents that allow the best 
possible activation of the carboxyl terminal of the amino acid Aib [10]. In this work, the 
combination of two groups of coupling reagents was studied, N,N′-
Diisopropylcarbodiimide/1-Hydroxybenzotriazole (DIC/HOBt) and N,N′-
Diisopropylcarbodiimide/Ethyl 2-cyano-2-(hydroxyimino)acetate (DIC/Oxima), to 
compare their reaction yields and purity using Solid Phase Peptide Synthesis assisted by 
Microwave heating (MW-SPPS) method, in a pre-loaded Phe-Wang resin. In addition, 
solubility and antimicrobial tests were performed. 
2. Experiments 
2.1. Materials 
Microwave synthesis was performed on the manual peptide synthesizer Discover 
SPPS (CEM Corporation). The solid supports used were Fmoc-Phe-Wang resin with a 
functionalization degree of 0.51 mmol/g acquired from AAPPtec. The 1H nuclear magnetic 
resonance spectra were obtained on the Bruker Avance III 400 device at a frequency of 400 
MHz, using the solvent peak as an internal reference, at 25 °C. The deuterated solvent 
used was deuterated chloroform (CDCl3d6) with a deuteration degree greater than 99.8% 
(Acros Organics). Coupling constants (J) were obtained in Hertz (Hz) and chemical shifts 
(δ) in parts per million (ppm). Analytical High Performance Liquid Chromatography 
(HPLC) analysis was performed with a Licrospher 100 RP18 column (5 µm) in an HPLC 
system composed of a Jasco PU-980 pump, coupled to a Shimadzu SPD-GAV UV/vis 
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detector and a Shimadzu C-RGA Chromatopac recorder. The dry reagents and solvents 
were used as purchased commercially (AAPPtec, Louisville, KY, USA; Acros Organic, 
Geel, Belgium; Sigma Aldrich, St. Louis, MO, USA; Merck, Kenilworth, NJ, USA). Growth 
media Mueller Hinton broth (MHB) was obtained from CondaLab. Gram-negative E. coli 
(ATCC 25922) and P. aeruginosa (ATCC 25853) and Gram-positive S. aureus (ATCC 6538) 
and S. epidermidis (ATCC 35984) bacteria were supplied from American Type Culture 
Collection (ATCC). 
2.2. Synthesis of Peptaibolin by MW-SPPS on Wang Resin 
2.2.1. DIC/HOBt as Coupling Reagents 
Starting from 1.1 g of Fmoc-Phe-Wang resin (0.51 mmol/g), Fmoc group was removed 
by adding 5 mL of a 20% piperidine solution in dimethylformamide (DMF) to the reaction 
vessel containing the resin. The vessel was placed with the optical fiber for temperature 
measurement in the microwave and the SPPS deprotection program was chosen at 75 °C 
and 20 watts (W) for 30 s. After this initial deprotection, the 20% piperidine solution in 
DMF was filtered and 7 mL of this solution was added again, and the same program was 
selected for 3 min. The solution was filtered and washes were performed: DMF (3×) and 
methanol (MeOH) (3×), repeating this washing cycle four times. Then, all amino acids 
were sequentially coupled by introducing Fmoc-Aib-OH, Fmoc-Leu-OH, Fmoc-Aib-OH, 
and Fmoc-Leu-OH sequentially. The N-protected amino acid (0.0028 mol, 5 equiv.), HOBt 
(0.0028 mol, 0.4756 g, 5 equiv.), and DIC (0.0028 mol, 0.35 mL, 5 equiv) were dissolved and 
the reaction mixture containing the amino acid Aib required a stirring period of 2 h and 
the reaction mixture containing the amino acid leucine (Leu) remained stirring for 5 min. 
After two cycles of coupling with the conditions of 75 °C and 20 W for 5 min, the following 
washes were performed: DMF (3×) and MeOH (3×), three wash cycles. 
Prior to the separation of the peptide from the resin, acetylation was carried out, in 
which the resin was suspended in 7 mL of dry DMF, 1 mL of N,N-Diisopropylethylamine 
(DIPEA) (14 equiv.), and then 0.4 mL of acetic anhydride (7 equiv.) were added. The 
mixture was left under stirring for 1.5 h. After that period, the resin was washed with 
DMF (2×), MeOH (2×), dichloromethane (DCM) (3×), and ethyl ether (3×). The resin was 
dried in the desiccator at room temperature. 
After obtaining the final sequence and acetylation, the peptide Ac-Leu-Aib-Leu-Aib-
Phol was separated from the Wang resin. In a 3-port flask, sodium borohydride (NaBH4) 
(5 equiv.) was suspended in dry tetrahydrofuran (THF) (16 mL/g resin) under nitrogen 
atmosphere, dry ethanol (EtOH) (4 mL/g resin), and lithium bromide (LiBr) (5 equiv.). The 
mixture was vigorously stirred for 15 min in an ice bath and a further 15 min at room 
temperature. The resin was added to the previous mixture and left to stir at room 
temperature for a period of 24 h. 
The separation of the resin from the reaction mixture was done through filtration into 
a porous plate funnel and washed with THF (2×), EtOH (2×), and ethyl acetate (EtOAc) 
(2×), directly into a 100 mL round bottom flask. Acetic acid was added dropwise in order 
to eliminate all the borohydride present in the mixture. The solvent was evaporated 
without heating and proceeded to the extraction, using a combination of water 
(H2O):EtOAc:saturated sodium chloride (NaCl) solution (3×). The organic phase was 
collected and dried using anhydrous magnesium sulfate (MgSO4). After filtration, the 
solvent was evaporated to dryness without heating. Ethyl ether was added and placed in 
the cold. The solution was centrifuged until a white solid was obtained. 
2.2.2. DIC/Oxima as Coupling Reagents 
Starting from 1.1 g of Fmoc-Phe-Wang resin (0.51 mmol/g), the protective group was 
removed by adding 5 mL of a 20% piperidine solution in DMF to the reaction vessel 
containing the resin. The vessel was placed with the optical fiber for temperature 
measurement in the microwave and the SPPS deprotection program was chosen at 75 °C 
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and 20 W for 30 s. After this initial deprotection, the 20% piperidine solution in DMF was 
filtered and 7 mL of this solution was added again, and the same program was selected 
again for 3 min. The solution was filtered and washes were performed, DMF (3x) and 
MeOH (3x), repeating this washing cycle 4 times. Then, all amino acids were sequentially 
coupled by introducing Fmoc-Aib-OH, Fmoc-Leu-OH, Fmoc-Aib-OH, and Fmoc-Leu-
OH, sequentially. The N-protected amino acid (0.0028 mol, 5 equiv.), Oxima (0.0028 mol, 
0.3986 g, 5 equiv.), and DIC (0.0028 mol, 0.35 mL, 5 equiv.) were dissolved, and the reac-
tion mixture containing the amino acid Aib required a stirring period of 2 h and the reac-
tion mixture containing the amino acid Leu remained stirring for 5 min. After two cycles 
of coupling with the conditions of 75 °C and 20 W for 5 min, the following washes were 
performed: DMF (3×) and MeOH (3×), 3 wash cycles. Prior to the separation of the peptide 
from the resin, acetylation was carried out, in which the resin was suspended in 7 mL of 
dry DMF, 1 mL of DIPEA (14 equiv.), and then 0.4 mL of acetic anhydride (7 equiv.) were 
added. The mixture was left under stirring for 1.5 h. After that period, the resin was 
washed with DMF (2×), MeOH (2×), DCM (3×), and ethyl ether (3×). The resin was dried 
in the desiccator at room temperature. 
After obtaining the final sequence and acetylation, the peptide Ac-Leu-Aib-Leu-Aib-
Phol was separated from the Wang resin. In a 3-port flask, NaBH4 (5 equiv.) was sus-
pended in dry THF (16 mL/g resin) under nitrogen atmosphere, dry ethanol (4 mL/g 
resin), and LiBr (5 equiv.). The mixture was vigorously stirred for 15 min in an ice bath 
and a further 15 min at room temperature. The resin was added to the previous mixture 
and left to stir at room temperature for a period of 24 h. 
The separation of the resin from the reaction mixture was done through filtration into 
a porous plate funnel and washed with THF (2×), EtOH (2×), and EtOAc (2×), directly into 
a 100 mL round bottom flask. Acetic acid was added dropwise in order to eliminate all 
the borohydride present in the mixture. The solvent was evaporated without heating and 
proceeded to the extraction, using a combination of H2O:EtOAc:saturated NaCl solution 
(3×). The organic phase was collected and dried using anhydrous MgSO4. After filtration, 
the solvent was evaporated to dryness without heating. Ethyl ether was added and placed 
in the cold. The solution was centrifuged until a white solid was obtained. 
2.3. Peptaibolin Caracterization: Proton Nuclear Magnetic Resonance (1H NMR) 
For structural confirmation, 5 mg of peptide was dissolved in 500 µL of CDCL3d6 and 
transferred to an NMR tube and NMR spectrum was recorded at 400 MHz. 
2.4. Peptaibolin Caracterization: High Performance Liquid Chromatography (HPLC) 
To confirm the purity, three eluent solutions were prepared. Filtering all solvents, 
300 mL of the eluent solution acetonitrile/water (ACN/H2O) (1:1), ACN/H2O (2:1), and 
ACN/H2O (1:2) was prepared, adding 0.1% trifluoroacetic acid (TFA), and all solutions 
were placed in an ultrasonic bath for 20 min. 
2.5. Solubility Tests Preparation 
Several solvents have been tested so that the dissolution of Peptaibolin takes place. 
For each solvent tested, a specific peptide mass was weighed and tried to dissolve in 1 mL 
of solution. For the combination of 10% dimethyl sulfoxide (DMSO) in H2O (2 mg); for 
10% hydrochloric acid (HCL)/H2O (1.9 mg); for 100% HCL (1.8 mg); for phosphate-buff-
ered saline (PBS) (2.4 mg); for NaCl/H2O (2 mg); for Acetic acid/H2O (1.9 mg); for 10% 
CDCL3 (2 mg); and for ACN/H2O (2.1 mg). 
2.6. Minimum Inhbitory Concentration (MIC) 
Working solutions at 8 mg/mL were prepared using the most suitable solvent. Ali-
quots were added to the first column of 96-well plates in a volume of 100 µL. Serial dilu-
tions (1:2) were made with MHB in the consecutive wells, to a final volume of 50 µL. Then, 
Proceedings 2021, 78, 47 5 of 7 
 
 
to each of these wells, 50 µL of the bacteria suspensions prepared at 2 × 107 CFUs/mL in 
MHB were added (inoculated from one colony and grown overnight at 37 °C and 100 
rpm), meaning the starting peptide concentration in contact with the bacteria was at 4 
mg/mL. Agent-free bacteria suspensions (positive) and culture media (negative) were 
used as controls. Absorbance readings at a wavelength of 600 nm (EZ READ 2000 Micro-
plate Reader, Biochrom, UK) were made before and after plate incubation for 24 h at 37 
°C and 100 rpm. The MIC value for each peptide/bacteria combination was established as 
the concentration at which bacteria did not show any growth, determined visually, and 
confirmed by the differences in absorbance readings. 
3. Results and Discussion 
3.1. Synthesis of Peptaibolin by MW-SPPS on Wang Resin 
Peptaibolin was synthesized according to the MW-SPPS method where each amino 
acid is sequentially coupled with the aid of a combination of coupling reagents in order 
to favor the activation of the carboxylic group and potentiate the formation of the peptide 
bond between two amino acid residues. Despite the fact that Peptaibolin is a widely stud-
ied peptide, which mechanisms of action and antimicrobial activity have already been 
proven and further studies have been already performed by replacing the amino acid Aib 
with its analogues to potentiate its activity, the search for different coupling reagent com-
binations has never been much addressed. Two combinations were tested: DIC/HOBt and 
DIC/Oxima. After obtaining the white solid by centrifugation and after a drying period in 
a desiccator, the mass obtained from each peptide was weighed and their yields were 
calculated. It was proved that the combination of DIC/Oxima coupling reagents had a 
higher yield as well as a higher purity, confirmed by the retention time obtained by the 
analytical HPLC technique using ACN/H2O (1:1) + 0.1% TFA as eluent (Table 1). 
Table 1. Comparison between the two coupling reagent combinations in terms of obtained mass, 
reaction yield, and retention time purity. 
Coupling Reagents Mass (g) Yeld (%) Retention Time (min) 
DIC/HOBt 0.1222 40.6 6232 
DIC/Oxima 0.1520 50.0 6942 
Structural confirmation was made only by 1H NMR for each peptide synthesized 
with different coupling reagents where it was proved that both peptides contained all the 
amino acids coupled in the right positions. 
DIC/HOBt: RMN de 1H (CDCl3d6, 400 MHz) δH = 0.90–1.00 (12H, m, 4xCH3-Leu); 
1.37 (3H, s, J = 6.8 Hz, CH3-Aib); 1.38 (3H, s, J = 6.4 Hz, CH3-Aib); 1.48 (3H, s, CH3-Aib); 
1.54 (3H, s, CH3-Aib); 1.58–1.89 (6H, m, βCH2-Leu + γCH-Leu); 2.14 (3H, s, CH3CO); 2.77–
2.83 (2H, m, βCH2-Phe); 3.62–3.69 (2H, m, CH2OH); 3.96 (1H, s, αCH-Leu); 4.02–4.08 (1H, 
m, αCH-Leu); 4.29 (1H, s, αCH-Leu); 7.17–7.30 (5H, m, CH-Phol); 7.85 (1H, s, NH-Leu); 
8.02 (1H, s, NH); 8.11 (1H, s, NH). 
DIC/Oxima: RMN de 1H (CDCl3d6, 400 MHz) δH = 0.97–1.00 (12H, m, 4xCH3-Leu); 
1.38 (3H, s, CH3-Aib); 1.39 (3H, s, CH3-Aib); 1.48 (3H, s, CH3-Aib); 1.54 (3H, s, CH3-Aib); 
1.58–1.89 (6H, m, βCH2-Leu + γCH-Leu); 2.14 (3H, s, CH3CO); 2.73–2,83 (5H, m, βCH2- 
Phe); 3.61–3.72 (2H, m, CH2OH); 3.96 (1H, s, α-CH); 4.02–4.08 (1H, m, αCH-Leu); 4.29 (1H, 
s, α-CH-Leu); 7.15–7.30 (5H, m, CH-Phol); 7.86 (1H, s, NH); 8.06 (1H, s, NH); 8.15 (1H, s, NH). 
3.2. Evaluation of Solubility Properties of Peptaibolin 
The solubility of an AMP is an important factor and it is crucial that the peptide is 
soluble in suitable and compatible solvents for antimicrobial tests. The use of toxic sol-
vents is not interesting for this type of test since they cannot be applied in a biological 
context and therefore, cannot be biomedically applied. Solubility tests were performed 
only on the peptide synthetized with DIC/Oxima, mostly because of the highest amount 
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of mass and yield. The most suitable solvent should be 100% H2O due to its inert proper-
ties, being sure that it would not interfere with the antibacterial results. However, it was 
concluded that the peptide was not soluble in water, requiring the addition of other types 
of organic solvents or even the dissolution of the peptide in a total volume of organic 
solvents (Table 2). 
Table 2. Combinations of solvents tested and the effects obtained on Peptaibolin in a total volume 
of 1 mL solution. 
Solvents Tested (VT = 1 mL) Dissolution Effect 
10% DMSO/H2O Soluble 
ACN/H2O Dissolves only with large amounts of ACN 
NaCl/H2O Does not dissolve 
Acetic Acid/H2O Peptide precipitation 
PBS Does not dissolve 
10% HCl/H2O Does not dissolve 
100% HCL Does not dissolve 
100% H2O Does not dissolve 
10% CDCl3 Partially soluble 
3.3. Antibacterial Assessment 
MIC evaluations were conducted using 10% DMSO solvent in water. This was found 
as the most suitable solvent for the peptide and as such was applied in contact with the 
bacteria. After 24 h of incubation, precipitates were detected in the most Peptaibolin con-
centrated wells, namely those containing 4 mg/mL of the peptide solution. Bacteria was 
also found to grow over the incubation period. Data reported no action against the se-
lected microorganisms, meaning that if it was possible to find an MIC for this peptide, it 
would be superior to 4 mg/mL. In terms of biomedical or pharmacological applications, 
this concentration is considered too elevated and, as such, not suitable for a cost-effective 
mass production. 
4. Conclusions 
Although the discovery of Peptaibolin as an AMP is not a recent topic in scientific 
research and there have been several studies focusing on its optimization, this peptide is 
most often synthesized according to standard procedures and without varying its combi-
nation of coupling reagents. Nowadays, there are a variety of coupling reagents commer-
cially available from the most traditional carbodiiamides, such as DIC, which is most fre-
quently used in SPPS, to auxiliate nucleophiles such as HOBt. According to the results 
obtained, it can be concluded that the DIC/Oxima combination, in addition to maintaining 
the characteristics of Peptaibolin, provides better yields with the same level of purity. Fur-
thermore, this alternative is even more positive because it replaces the traditional HOBt, 
which has explosive characteristics. Solubility tests were also performed to study the be-
havior of Peptaibolin in various solvents and to test its solubility. Being a small peptide 
and showing nonpolar characteristics, it was expected that its dissolution on H2O would 
be an obstacle, which has been proven, since this peptide is only soluble in organic sol-
vents or in organic solvents in combination with H2O, making it unsuitable for biomedical 
applications as AMP. Its lack of antibacterial activity was also proven with a certain 
amount of Peptaibolin being dissolved in 10% DMSO/H2O (the most promising solvent). 
Microbiological tests were carried out on Gram-positive bacteria and Gram-negative bac-
teria. However, MIC studies demonstrated the resistance of bacteria to the peptide action 
and the peptide instability in bacterial growth conditions. 
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